India's clinical knowledge, organised.

OpenInsight is only as good as its sources. Here's exactly what we include — and why.

Our Data Sources

Curated, prioritised, India-first

Source
Type
Update Frequency
Coverage
ICMR Guidelines
National protocols
Monthly
All major diseases
CDSCO Drug Database
Regulatory
Bi-weekly
Approved drugs & schedules
NTEP (TB)
National programme
Quarterly
Drug-resistant TB, PMDT
NVBDCP
Vector-borne disease
Quarterly
Malaria, Dengue, Filariasis
State STGs
State guidelines
Variable
State-specific protocols
PubMed Central (OA)
Research literature
Weekly
Open-access journals
WHO India
Global-regional
Monthly
International guidance
Cochrane Reviews
Meta-analyses
Quarterly
High-evidence syntheses

What we don't do

Honest about our limits

1

We don't replace clinical judgment

OpenInsight is a decision support tool, not a diagnostic engine. The final clinical decision always rests with the doctor.

2

We don't hide our sources

Every response shows where the information came from. If you disagree with the synthesis, the raw evidence is always visible.

3

We don't accept payments to influence clinical answers

Sponsored content is always clearly separated from clinical responses. Your clinical answer is never influenced by pharmaceutical incentives.

Evidence quality markers

Each response shows which tier of evidence it's drawing from

RCT

Randomised Controlled Trial — highest quality for intervention evidence

Meta-analysis

Systematic review of multiple studies — comprehensive synthesis

National Guideline

ICMR, NTEP, CDSCO — authoritative for India

Expert Consensus

Specialist panel recommendation — when evidence is limited

Case Series

Observational data — lower evidence but valuable for rare conditions